Depleting RNF25 expression substantially inhibited the proliferation of gefitinib-resistant NSCLC cells by inducing apoptosis through the suppression of NF-κB signaling and EGFR-independent reactivation of ERK during a prolonged drug treatment. This evidence concerns the gene RNF25 and non-small cell lung carcinoma.